Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akash Nanda

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Lung Cancer|October 1, 2008
Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancerAkash Nanda, Dora C Dias-Santagata, Hannah Stubbs, et al.
Clinical Genitourinary Cancer|May 25, 2015
Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality RiskLior Z Braunstein, Ming-Hui Chen, Daniel E Dosoretz, et al.
European Urology|September 18, 2012
Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery diseaseAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapyAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.
International Journal of Radiation Oncology, Biology, Physics|September 12, 2009
Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapyAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.
Cancer Research|February 12, 2004
TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI)Akash Nanda, Eleanor B Carson-Walter, Steven Seaman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2006
Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumorsAkash Nanda, Baktiar Karim, Zhongsheng Peng, et al.
Cancer Research|August 20, 2011
EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaksMeng Wang, Fabian Morsbach, David Sander, et al.
Cancer Research|December 3, 2004
Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7RAkash Nanda, Phillip Buckhaults, Steven Seaman, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2016
Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trialRaquibul Hannan, Vasu Tumati, Xian-Jin Xie, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Lung Cancer|October 1, 2008
Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancerAkash Nanda, Dora C Dias-Santagata, Hannah Stubbs, et al.
Clinical Genitourinary Cancer|May 25, 2015
Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality RiskLior Z Braunstein, Ming-Hui Chen, Daniel E Dosoretz, et al.
European Urology|September 18, 2012
Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery diseaseAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapyAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.
International Journal of Radiation Oncology, Biology, Physics|September 12, 2009
Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapyAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.
Cancer Research|February 12, 2004
TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI)Akash Nanda, Eleanor B Carson-Walter, Steven Seaman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2006
Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumorsAkash Nanda, Baktiar Karim, Zhongsheng Peng, et al.
Cancer Research|August 20, 2011
EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaksMeng Wang, Fabian Morsbach, David Sander, et al.
Cancer Research|December 3, 2004
Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7RAkash Nanda, Phillip Buckhaults, Steven Seaman, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2016
Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trialRaquibul Hannan, Vasu Tumati, Xian-Jin Xie, et al.
Pageof 3